Investing Profile

Kyle Kurpinski(3)

VCInvestor
Executive Director, Investments, Tencent Exploration Team
tenx.tcSeattle, Washington
Photo of Kyle Kurpinski, Investor at Tencent Holdings
Your Intro Paths to Kyle Kurpinski

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Kyle is a member of
University of California, Berkeley Network
246 CONNECTIONS
University of Michigan Network
87 CONNECTIONS

Find Kyle Kurpinski on

Current Investing Position
Tencent Holdings Investor
Investment Range
$100K - $30.0M
Sweet Spot
$15.0M
Investments On Record
15

Kyle Kurpinski is on these Sector & Stage Rankings

Kyle Kurpinski's Investments On Record (13)

CompanyStageDateRound SizeTotal Raised
Metagenomi
Series BJan 2022$180M
$280M
Co-investors: Victor Wang (HOF Capital), Sebastian Bernales (Humboldt Fund), Andrew Levin (RA Capital), Jeremy Yap
Culture Biosciences
Series BOct 2021$80M
seedApr 2018
$100M
Co-investors: Wei Guo (UpHonest Capital), Ben Davenport (Blockchain Capital), Zal Bilimoria (Refactor Capital), Dan Phillips (Sandbox Industries), Andrew Lee (Northpond Ventures), Michael Dempsey (Compound), Steven Lurie (Team Builder Ventures)
Lassogen
Seed RoundOct 2020$4.5M
$9.5M
Co-investors: Peter Barrett (Playground Global), Wes Selke (Better Ventures), Phyllis Whiteley (Playground Global)
Mantra Bio
Series AJul 2020$25M
$34M
Co-investors: David Moskowitz (8VC), Francisco Gimenez (8VC)
Atomwise
Series AMar 2018$45M
$170M
Co-investors: Raj Ganguly (B Capital Group), Kiersten Stead (DCVC (Data Collective)), Matt Ocko (DCVC (Data Collective)), David E. Weekly (Mexican.vc), Xinhong Lim (Vickers Venture Partners), Saman Farid (Baidu Ventures), Farzad Nazem
Locus Biosciences
Series ANov 2017$19M
$54M
Co-investors: Stuart Peterson (Artis Ventures (AV)), Austin Walne (Artis Ventures (AV))
Karius
Series AAug 2017$59M
$330M
Co-investors: Ravi Mhatre (Lightspeed Venture Partners), Alex Morgan (Khosla Ventures), Matt Ocko (DCVC (Data Collective)), Isabelle de Cremoux (Seventure Partners)
Guardant Health
Series EMay 2017$360M
Series DJan 2016$100M
$550M
Co-investors: Samir Kaul (Khosla Ventures), Pejman Nozad (Pear VC), Matthew Rizzo (OrbiMed), Sujay Jaswa (WndrCo LLC), Ling Wong (Highbury Group), Bobby Yazdani (Cota Capital), Chris Schaepe, David Chen, Farzad Nazem, Laszlo Bock

most interested in

I'm most interested in companies building deep core technologies to solve complex challenges in human health and planetary resiliency. I'm particularly drawn towards data-driven companies, and I focus heavily on those innovating at the intersection of data science and life science. I'm intrigued by the possibilities of using robotics, automation, miniaturization, and new high-throughput techniques to rapidly generate novel and actionable insights for users.

not interested in

I generally do not invest companies that lack a clear and defensible core technology.

Kyle Kurpinski's Education

University of California, Berkeley PhD Bioengineering
University of Michigan BS Chemical Engineering